Marshall Wace North America’s Dentsply Sirona XRAY Stock Holding History

Marshall Wace North America’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$67.4M	Sell	1,161,004 -1,302,629	-53%	-$80.3M	0.29%	74
2021 Q2	$156M	Buy	2,463,633 +1,253,906	+104%	+$82.6M	0.65%	24
2021 Q1	$77.2M	Buy	+1,209,727	New	+$70.2M	0.32%	64
2020 Q2	–	Sell	-180,725	Closed	-$7.02M	–	1532
2020 Q1	$7.02M	Buy	+180,725	New	+$9.21M	0.05%	267
2019 Q1	–	Sell	-30,807	Closed	-$1.15M	–	1957
2018 Q4	$1.15M	Buy	+30,807	New	+$1.12M	0.01%	580
2018 Q2	–	Sell	-10,399	Closed	-$523K	–	1741
2018 Q1	$523K	Buy	+10,399	New	+$612K	﹤0.01%	1143
2017 Q4	–	Sell	-168,992	Closed	-$10.1M	–	1643
2017 Q3	$10.1M	Buy	168,992 +67,109	+66%	+$3.99M	0.06%	359
2017 Q2	$6.62M	Sell	101,883 -191,712	-65%	-$12.1M	0.05%	418
2017 Q1	$18.2M	Buy	+293,595	New	+$17.7M	0.14%	185
2013 Q4	$3.44M	Sell	70,894 -326,643	-82%	-$15.3M	0.07%	224
2013 Q3	$17.3M	Buy	+397,537	New	+$17M	0.53%	48

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Marshall Wace North America's XRAY Position: Q3 2021 in Review

Marshall Wace North America reduced its Dentsply Sirona (XRAY) stake by 53% in Q3 2021, selling an estimated $80.3M and leaving 1,161,004 shares worth $67.4M. The position accounts for 0.29% of the portfolio, ranked #74.

Marshall Wace North America first reported a position in XRAY in Q3 2013 and has held it in 11 quarters since. The position peaked at $156M in Q2 2021. 554 funds tracked by Wall St. Rank hold XRAY as of Q3 2021.

Marshall Wace North America held 1,161,004 shares of Dentsply Sirona worth $67.4M as of Q3 2021.
Marshall Wace North America sold 1,302,629 Dentsply Sirona shares in Q3 2021, an estimated $80.3M.
Dentsply Sirona made up 0.29% of Marshall Wace North America's portfolio in Q3 2021, its #74 holding.
Marshall Wace North America first reported a position in Dentsply Sirona in Q3 2013 and has held it in 11 quarters since.
Marshall Wace North America's Dentsply Sirona position peaked at $156M in Q2 2021.
554 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.